세계의 키토산 시장 : 원료, 등급, 용도, 지역별 예측(-2032년)

Global Chitosan Market Research Report Information by Source (Shrimps, Prawns, Crabs, Lobsters, Fungi), By Grade (Food Grade, Industrial Grade, and Pharmaceutical Grade), By Application (Food & Beverages, Medical & Pharmaceuticals, Cosmetic, Water Treatment, Agrochemicals), And by Region (North America, Europe, Asia-Pacific, Middle East and Africa, South America) - Forecast Till 2032

Market Overview

In 2023, the Chitosan Market Size was estimated to be USD 1,326.55 million. The Chitosan market industry is anticipated to experience a compound annual growth rate (CAGR) of 15.5% from 2024 to 2032, resulting in a total market value of USD 5,170.37 million. The demand for chitosan in cosmetics is anticipated to continue its upward trajectory as consumers endeavor to find safer and more sustainable alternatives in personal care products. In general, it is anticipated that the Chitosan Market will advance in the years ahead because of the convergence of these factors.

The Chitosan Market is presented with a substantial opportunity to expand due to the increasing global awareness of health. The demand for products that are derived from natural, sustainable sources and offer health benefits is on the rise as consumers become more informed about health and wellness. Increasing health awareness and the increasing prevalence of obesity and overweight present a significant opportunity for the Chitosan market.

Market segment insights

Based on the source, the Chitosan Market segmentation comprises Shrimps, Prawns, Crabs, Lobsters, and Fungi.

The Chitosan Market is segmented by Grade, which includes Pharmaceutical Grade, Industrial Grade, and Food Grade.

The Chitosan Market is segmented by application, including Food & Beverages, Medical & Pharmaceuticals, Cosmetic, Water Treatment, and Agrochemicals.

Analysis of the Region

The North American region's impressive 14.9% CAGR and substantial market share of 36.12%. The global chitosan market is significantly influenced by North America, which includes the United States, Canada, and Mexico. The location's various business programs, stringent regulatory requirements, and robust emphasis on sustainability and innovation contribute to the growing demand for chitosan.

Europe, with its diverse monetary panorama and sturdy regulatory frameworks, performs a big role within the worldwide chitosan marketplace. Germany's strong healthcare and pharmaceutical sectors leverage chitosan for drug delivery structures, wound care, and tissue engineering because of its biocompatibility and non-toxicity. Germany is a hub for biomedical research, driving improvements in chitosan packages and improving its marketplace capability.

Asia-Pacific region, including major economies such as China, India, Japan, Australia & New Zealand, South Korea, rest of Asia-Pacific, plays a major role in the Chitosan Market Reduction in consumption Chinese government policies will support sustainable agriculture and organic agriculture are providing chitosan-based products with increasing adoption.

South America, with its rich natural resources and developing technologies, is emerging as an important country in the Chitosan Market. Brazil, Argentina, and other countries in this region are increasingly exploiting the versatility of chitosan for a variety of purposes, including agriculture, water purification, pharmaceuticals, etc.

The Middle East African region including GCC countries, Turkey, North Africa and South Africa is contributing significantly to the growth of the Chitosan Market. The GCC countries face severe water scarcity and rely heavily on desalination.

Major Players

Key Companies in the Chitosan market include Golden-Shell Pharmaceutical, Primex ehf, Dainichiseika Color & Chemicals Mfg.., Ltd, Marshall Marine Products, KitoZyme, Qingdao Yunzhou Biochemistry Co. Ltd., Heppe Medical Chitosan GmbH, Advanced Biopolymers AS, Meron, Panvo Organics Pvt Ltd, and Others.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 MARKET ATTRACTIVENESS ANALYSIS
  • 1.1.1 GLOBAL CHITOSAN MARKET, BY SOURCE
  • 1.1.2 GLOBAL CHITOSAN MARKET, BY GRADE
  • 1.1.3 GLOBAL CHITOSAN MARKET, BY APPLICATION

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 KEY BUYING CRITERIA

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 CONSUMPTION & NET TRADE APPROACH
  • 3.6.2 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1. INCREASING DEMAND FROM FOOD & BEVERAGES INDUSTRY
  • 4.2.2. GROWING DEMAND IN WASTEWATER TREATMENT AND COSMETIC INDUSTRY
  • 4.2.3. DRIVER IMPACT ANALYSIS (2020-2032)
• 4.3 RESTRAINTS
  • 4.2.4. LIMITED AVAILABILITY OF RAW MATERIALS
  • 4.2.5. HIGHER PRODUCTION COST
  • 4.2.6. RESTRAINT IMPACT ANALYSIS (2020-2032)
• 4.4 OPPORTUNITY
  • 4.4.1 GROWING AWARENESS ABOUT HEALTH ON A GLOBAL SCALE
  • 4.2.7. UNIQUE PROPERTIES AND GROWING AWARENESS TOWRADS BENEFITS OF CHITOSAN
• 4.5 CHALLENGES
  • 4.5.1 STRINGENT REGULATIONS ON SHRIMP FARMING
  • 4.5.2 STRIKING DRAWBACKS OF CHITOSAN PRODUCTS IN DRUG DELIVERY SYSTEMS
• 4.6 COVID-19 IMPACT ANALYSIS
  • 4.6.1 IMPACT ON PRODUCTION
  • 4.6.2 IMPACT ON SUPPLY CHAIN
  • 4.6.3 IMPACT ON PRICING
  • 4.6.4 IMPACT ON APPLICATION AREAS
  • 4.6.5 IMPACT ON SALES CHANNEL
  • 4.6.6 IMPACT ON MANUFACTURERS, & ECONOMIES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 RAW MATERIAL ACQUISITION AND PROCESSING
  • 5.1.2 TRANSFORMING CHITIN INTO CHITOSAN
• 5.2 SUPPLY CHAIN ANALYSIS
  • 5.2.1 RAW MATERIAL ACQUISITION
  • 5.2.2 PROCESSING AND MANUFACTURING
  • 5.2.3 DISTRIBUTION AND LOGISTICS
• 5.3 PORTER'S FIVE FORCES MODEL
  • 5.3.1 BARGAINING POWER OF SUPPLIERS
  • 5.3.2 BARGAINING POWER OF BUYERS
  • 5.3.3 THREAT OF NEW ENTRANTS
  • 5.3.4 THREAT OF SUBSTITUTES
  • 5.3.5 INTENSITY OF RIVALRY
• 5.4 IMPACT OF COVID-19 OUTBREAK ON GLOBAL CHITOSAN
  • 5.4.1 IMPACT ON PRODUCTION
  • 5.4.2 IMPACT ON SUPPLY CHAIN
  • 5.4.3 IMPACT ON APPLICATION AREAS
  • 5.4.4 ECONOMIC IMPACT ON CHITOSAN MARKET

6 GLOBAL CHITOSAN MARKET, BY SOURCE

• 6.1 INTRODUCTION
• 6.2 SHRIMPS
• 6.3 PRAWNS
• 6.4 CRABS
• 6.5 LOBSTERS
• 6.6 FUNGI

7 GLOBAL CHITOSAN MARKET, BY GRADE

• 7.1 INTRODUCTION
• 7.2 FOOD GRADE
• 7.3 INDUSTRIAL GRADE
• 7.4 PHARMACEUTICAL GRADE

8 GLOBAL CHITOSAN MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 FOOD & BEVERAGE
• 8.3 MEDICAL & PHARMACEUTICALS
• 8.4 COSMETIC
• 8.5 WATER TREATMENT
• 8.6 AGROCHEMICALS

9 GLOBAL CHITOSAN MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
  • 9.2.3 MEXICO
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 UK
  • 9.3.3 FRANCE
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 RUSSIA
  • 9.3.7 BENELUX
  • 9.3.8 NORDICS
  • 9.3.9 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 AUSTRALIA & NEW ZEALAND
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
  • 9.5.2 ARGENTINA
  • 9.5.3 REST OF SOUTH AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GCC COUNTRIES
  • 9.6.2 TURKEY
  • 9.6.3 NORTHERN AFRICA
  • 9.6.4 SOUTHERN AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 COMPETITION DASHBOARD
  • 10.2.1 PRODUCT PORTFOLIO
  • 10.2.2 REGIONAL PRESENCE
  • 10.2.3 STRATEGIC ALLIANCES
  • 10.2.4 INDUSTRY EXPERIENCES
• 10.3 MARKET SHARE ANALYSIS, 2023
• 10.4 WHO ARE THE MAJOR DISRUPTORS & INNOVATORS
• 10.5 WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS
• 10.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
• 10.7 LIST OF KEY PLAYERS/BRANDS, BY REGION
• 10.8 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.8.1 PRODUCT LAUNCH
  • 10.8.2 STRATEGIC COLLABORATION

11 COMPANY PROFILES

• 11.1 KITOZYME
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 PRIMEX EHF
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFEREDS
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 HEPPE MEDICAL CHITOSAN GMBH
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 KEY DEVELOPMENTS
  • 11.3.4 SWOT ANALYSIS
  • 11.3.5 KEY STRATEGIES
• 11.4 ADVANCED BIOPOLYMERS AS
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 MERON (MERON BIOPOLYMERS)
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 GOLDEN-SHELL PHARMACEUTICAL CO., LTD
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 PANVO ORGANICS PVT LTD.
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 MARSHALL MARINE PRODUCTS
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 DAINICHISEIKA COLOR & CHEMICALS MFG.CO. LTD
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 SWOT ANALYSIS
  • 11.10.6 KEY STRATEGIES
• 11.11 DATA CITATIONS